<i>De novo</i> autoimmune hepatitis following living‐donor liver transplantation for primary biliary cirrhosis
Kaname Yoshizawa(Shinshu University), Masayuki Nakano(Nihon University), Yūichi Nakazawa(Hokkaido University), Toshihiko Ikegami, Takeji Umemura(Shinshu University), Eri Imagawa(Yokohama City University), Yasuhiko Hashikura, Masao Ôta(Shinshu University), Eiko Hidaka, Eiji Tanaka(Tokushima University), Shinichi Miyagawa(Tokyo University of Science), Kenji Sano(Shinshu University Hospital), Kendo Kiyosawa(Aizawa Hospital), Haruaki Shirakawa(Shinshu University), Tetsuya Ichijo, Kazuyuki Matsuda
Cited by 27
Related Papers
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
|Journal of Hepatology|2003|1.6k
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
|Hepatology|1990|1.2k
Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging
|Radiology|2011|354
cHCC‐CCA
|Hepatology|2018|333
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272